Results showed GNSC-001 met the primary safety endpoint and was well-tolerated in all study subjects, including 12-month follow-up. Study findings noted elevated IL-1Ra expression in synovial fluid and an encouraging trend in symptomatic improvement. Osteoarthritis affects more than 30…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.